You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

MEPRO-ASPIRIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Mepro-aspirin, and what generic alternatives are available?

Mepro-aspirin is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in MEPRO-ASPIRIN is aspirin; meprobamate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MEPRO-ASPIRIN?
  • What are the global sales for MEPRO-ASPIRIN?
  • What is Average Wholesale Price for MEPRO-ASPIRIN?
Drug patent expirations by year for MEPRO-ASPIRIN
Recent Clinical Trials for MEPRO-ASPIRIN

Identify potential brand extensions & 505(b)(2) entrants

Herning HospitalN/A
Regionshospitalet Viborg, SkiveN/A
Randers Regional HospitalN/A

See all MEPRO-ASPIRIN clinical trials

US Patents and Regulatory Information for MEPRO-ASPIRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz MEPRO-ASPIRIN aspirin; meprobamate TABLET;ORAL 089127-001 Mar 2, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.